Title : Employing CRISPR-Cas9 to Generate CD133 Synthetic Lethal Melanoma Stem Cells.

Pub. Date : 2022 Feb 20

PMID : 35216449

1 Functional Relationships(s)
Compound Name
Protein Name
1 Conversely, Dox-induced CD133 expression diminished apoptosis in both trametinib-treated cell lines, coincident with elevated p-AKT, p-BAD, BCL-2, and BCL-xL and decreased activation of BAX and caspases-3 and -9. Doxorubicin caspase 3 Homo sapiens